基本信息
浏览量:6
职业迁徙
个人简介
I am a researcher, neurobiologist, and pre-clinical drug development expert, with over 12 years of experience studying neurodegenerative diseases. I'm passionate about translational science and the opportunity it holds in advancing novel therapies from “bench-to-bedside” for neurodegenerative diseases. I have vast expertise in leading projects and collaborations. As the Vice President of Research and development at NeuroSense Therapeutics, a clinical-stage drug development company developing a novel treatment for neurodegenerative diseases, I lead all pre-clinical projects, directing ideas from inception to the clinical phase. I instigate scientific discussions, spearhead the scientific strategy, and design the experimental protocols. My role includes obtaining grant funding and overseeing, publishing, and presenting scientific achievements. In addition, I view my role to be interdisciplinary, as I work in close coordination with the regulatory, clinical, and business development departments. I have published my work in leading journals and presented my research at worldwide scientific conferences, receiving multiple prizes and scholarships for my academic achievement.
A member of the BIO committee, a member of “Bashaar” – an academic community for society in Israel, and a member of “Midaat” -a non-profit organization promoting public health.
研究兴趣
论文共 13 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Inbal Maniv, Mahasen Sarji, Anwar Bdarneh,Alona Feldman,Roi Ankawa,Elle Koren, Inbar Magid-Gold,Noa Reis,Despina Soteriou,Shiran Salomon-Zimri,Tali Lavy, Ellina Kesselman,
Nature communicationsno. 1 (2023): 5922-14
Amyotrophic Lateral Sclerosis and Frontotemporal Degenerationno. 3-4 (2022): 263-271
Experimental eye research (2015): 17-25
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn